Valeant Pharma (VRX) Shares See Early Bounce Higher

November 9, 2016 8:56 AM EST

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Valeant Pharma (NYSE: VRX) shares are ticking higher early following a 22 percent drop on Monday amid weak Q3 results and cut outlook. The stock is up well over 2 percent ahead of the opening bell, going against broader market pressure.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Short Sales, Trader Talk

Add Your Comment